معرفی
Dr. Samantha Hayward serves as an Academic Clinical Lecturer at Bristol Medical School, University of Bristol, and is a member of the Bristol Doctoral College. Her clinical expertise centers on kidney disorders with advanced specialization in genomic and molecular epidemiological approaches.
Her educational credentials include:
- BMedSci (1st class honours)
- MBChB
- MRCP
Dr. Hayward's research program focuses on nephrotic syndrome, employing machine learning to decode genetic and epigenetic profiles for improved disease stratification and prognosis prediction. Her work bridges clinical nephrology with computational genomics, emphasizing molecular epidemiology in chronic kidney disorders and polypharmacy management in elderly renal patients.
Her publication portfolio reveals consistent investigation into epigenetic mechanisms in nephrotic syndrome, circulating factor disease pathogenesis, and international polypharmacy patterns in advanced chronic kidney disease. These works demonstrate interdisciplinary integration of clinical data, bioinformatics, and molecular techniques across nephrology, pharmacology, and machine learning domains.
Notable recognitions include:
- Kidney Research UK Paediatric Start-up Grant (2023)
- Research award for DNA methylation project in paediatric nephrotic syndrome (2021)
As Principal Investigator for the CRISPR-cas9 nephrotic syndrome project (2021-2025) and Co-Investigator on the European polypharmacy study (2017-2023), she directs substantial research initiatives funded by Kidney Research UK. Her grant portfolio supports innovative work combining bioinformatics, epigenetic analysis, and clinical epidemiology.
Dr. Hayward participates in international collaborative networks focused on renal disease mechanisms, evidenced by multi-country studies in the European Quality project and extensive cross-institutional partnerships in nephrology research.
